NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2. (Q48552047)

12 February 2018

title

NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2. (English)

1 reference

12 February 2018

0 references

Blom MA

1

1 reference

12 February 2018

van Twillert MG

2

1 reference

12 February 2018

de Vries SC

3

1 reference

12 February 2018

Engels F

4

1 reference

12 February 2018

Finch CE

5

1 reference

12 February 2018

Veerhuis R

6

1 reference

12 February 2018

Eikelenboom P

7

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 November 1997

1 reference

12 February 2018

published in

Brain Research

1 reference

12 February 2018

volume

777

1 reference

12 February 2018

page(s)

210-218

1 reference

12 February 2018

issue

1-2

1 reference

12 February 2018

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Rheumatoid arthritis and senile dementia of the Alzheimer's type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Clinical trial of indomethacin in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Risk of Alzheimer's disease and duration of NSAID use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Distribution pattern and functional state of complement proteins and alpha 1-antichymotrypsin in cerebral beta/A4 deposits in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Activated microglia and cerebral amyloid deposits in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Complement and cytokine gene expression in cultured microglial derived from postmortem human brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Inflammatory mechanisms in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Amyloid beta protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

New epidemiologic strategies in Alzheimer's disease may provide clues to prevention and cause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Anti-inflammatory drugs and Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Do nonsteroidal anti-inflammatory drugs have a protective effect against dementia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

IL-1 and anti-inflammatory drugs modulate A beta cytotoxicity in PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Dexamethasone regulation of the expression of cytokine mRNAs induced by interleukin-1 in the astrocytoma cell line U373MG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Recombinant human interleukin 1 beta induces production of prostaglandins in primary human fetal astrocytes and immortalized human fetal astrocyte cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

New colorimetric cytotoxicity assay for anticancer-drug screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Production of thromboxane and prostaglandins in human blood in the presence of thromboxane synthase inhibitors: a comparison of RIA and GC/MS determinations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Prostaglandin E2 potentiates interleukin-1 beta induced interleukin-6 production by human gingival fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Decreased prostaglandin synthesis in postmortem cerebral cortex from patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901204-3

10.1016/S0006-8993(97)01204-3

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

9449430

1 reference

12 February 2018